Open access
Aug 2026
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapse.
The 5-year overall survival of a DLI-based strategy can induce durable remission in patients with low-burden morphologic AML relapse after TCD alloSCT, even without prior cytoreduction.
J. Bergsma, E. Argiro, K. Oosterink et al.
· Transplantation and Cellular... · 1 citation